What is Arrowhead Pharmaceuticals Inc (ARWR) current stock price?

Arrowhead Pharmaceuticals Inc (ARWR) stock is trading at $73.56 with a +2.67% change.

What is the analyst consensus for ARWR stock?

Based on 12 analysts, the consensus rating for ARWR is 100% buy.

What is the AI rating for ARWR stock?

Clear Report's AI rating for ARWR is N/A out of 100.

What is the market trend for ARWR stock?

Insufficient moving average data to determine the trend for ARWR.

Is ARWR stock volatile?

Volatility data for ARWR is not available.

What is the 52-week range for ARWR?

52-week range data for ARWR is not available.

ARWR (Arrowhead Pharmaceuticals Inc) Stock Analysis

Clear Report

ARWR

—

Loading ARWR

Fetching market data and analysis

ARWR

—

Loading ARWR

Fetching market data and analysis

ARWR

—

AI OVERVIEW

INVESTOR SUMMARY

1 of 6 unlocked

Overall Market Environment:

No analysis available.

Fundamental Expectations:

Detailed AI commentary for this dimension is available with a subscription.

Structural Position:

Detailed AI commentary for this dimension is available with a subscription.

Market Perception:

Detailed AI commentary for this dimension is available with a subscription.

Risk Environment:

Detailed AI commentary for this dimension is available with a subscription.

Stability & Signal Reliability:

Detailed AI commentary for this dimension is available with a subscription.

OVERALL AI-RATING

—

N/A

Score 0-100

Weak:

0-39

Balanced:

40-69

Strong:

70-100

AI score based on multi-state analysis

TICKER STATE SUMMARY

Market state:

—

Risk:

Low

Confidence:

Moderate

KEY DRIVERS

Severe price damage

Price damage data unavailable.

Relative underperformance

Relative performance data unavailable.

Elevated volatility

Volatility data unavailable.

STATE ALIGNMENT

1 of 3 unlocked

Market bias

bearishneutralbullish

—

MARKET REGIME

Trend

—vs SMA200

No dataPhase: N/A

Insufficient data to assess trend.

Relative performance

••vs S&P 500 (3M)

Status: ••Benchmark: ••

MOVE QUALITY

Momentum

RSI (14):••

RSI Change (5D):••

Liquidity

Rel Vol:••

Avg Vol (30D):••

RISK ENVIRONMENT

Volatility

ATR (14):••

ATR Percentile:••

Price damage

Drawdown vs 52W High:••

FUNDAMENTALS & MARKET PERCEPTION

Earning outlook

EPS Revision (3M):••

Guidance:••

Analyst confidence

Target trend (3M):••

Coverage:••

Financial Health

Cash runway:••

Net debt:••

Narrative momentum

Dominant theme:••

Insider Trading Activity

InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalForm

Analyst Rating Changes

DateActionAnalystRatingPrice Target Change

Loading ARWR

Fetching market data and analysis

ARWR (Arrowhead Pharmaceuticals Inc) Stock Analysis · AI Forecast | Clear Report

AI OVERVIEW

INVESTOR SUMMARY

1 of 6 unlocked

Overall Market Environment:

No analysis available.

Fundamental Expectations:

Detailed AI commentary for this dimension is available with a subscription.

Structural Position:

Detailed AI commentary for this dimension is available with a subscription.

Market Perception:

Detailed AI commentary for this dimension is available with a subscription.

Risk Environment:

Detailed AI commentary for this dimension is available with a subscription.

Stability & Signal Reliability:

Detailed AI commentary for this dimension is available with a subscription.

OVERALL AI-RATING

—

N/A

Score 0-100

Weak:

0-39

Balanced:

40-69

Strong:

70-100

AI score based on multi-state analysis

TICKER STATE SUMMARY

Market state:

—

Risk:

Low

Confidence:

Moderate

KEY DRIVERS

Severe price damage

Price damage data unavailable.

Relative underperformance

Relative performance data unavailable.

Elevated volatility

Volatility data unavailable.

STATE ALIGNMENT

1 of 3 unlocked

Market bias

bearishneutralbullish

—

MARKET REGIME

Trend

—vs SMA200

No dataPhase: N/A

Insufficient data to assess trend.

Relative performance

••vs S&P 500 (3M)

Status: ••Benchmark: ••

MOVE QUALITY

Momentum

RSI (14):••

RSI Change (5D):••

Liquidity

Rel Vol:••

Avg Vol (30D):••

RISK ENVIRONMENT

Volatility

ATR (14):••

ATR Percentile:••

Price damage

Drawdown vs 52W High:••

FUNDAMENTALS & MARKET PERCEPTION

Earning outlook

EPS Revision (3M):••

Guidance:••

Analyst confidence

Target trend (3M):••

Coverage:••

Financial Health

Cash runway:••

Net debt:••

Narrative momentum

Dominant theme:••

Insider Trading Activity

InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalForm

Analyst Rating Changes

DateActionAnalystRatingPrice Target Change